Visceral angioedema due to angiotensin-converting enzyme inhibitor therapy

Cleveland Clinic Journal of Medicine

Volumn 78, Issue 5, 2011, Pages 297-304

  Korniyenko, Aleksandr ^a   Alviar, Carlos L ^a   Cordova, Juan P ^a   Messerli, Franz H ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ANGIONEUROTIC EDEMA; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INCIDENCE; MIDDLE AGED; PATHOLOGY; REVIEW; RISK FACTOR; VISCERA;

ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; LISINOPRIL; MIDDLE AGED; RISK FACTORS; VISCERA;

EID: 79955663599     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.78a.10102     Document Type: Review

References (74)

1. Brown NJ, Snowden M, Griffin MR. Recurrent angiotensinconverting enzyme inhibitor-associated angioedema. JAMA 1997; 278:232-233.
2. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117:234-242.
3. M esserli FH, Nussberger J. Vasopeptidase inhibition and angiooedema. Lancet 2000; 356:608-609.
4. J essup M, Brozena S. Heart failure. N Engl J Med 2003; 348:2007-2018.
5. J essup M. The less familiar face of heart failure. J Am Coll Cardiol 2003; 41:224-226.
6. Chobanian AV. Clinical practice. Isolated systolic hypertension in the elderly. N Engl J Med 2007; 357:789-796.
7. Casas JP, Chua W, Loukogeorgakis S, et al. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 2005; 366:2026-2033.
8. Weber MA, Messerli FH. Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk. Hypertension 2008; 51:1465-1467.
9. O udit G, Girgrah N, Allard J. ACE inhibitor-induced angioedema of the intestine: Case report, incidence, pathophysiology, diagnosis and management. Can J Gastroenterol 2001; 15:827-832.
10. Shahzad G, Korsten MA, Blatt C, Motwani P. Angiotensinconverting enzyme (ACE) inhibitor-associated angioedema of the stomach and small intestine: a case report. Mt Sinai J Med 2006; 73:1123-1125.
11. Chase MP, Fiarman GS, Scholz FJ, MacDermott RP. Angioedema of the small bowel due to an angiotensin-converting enzyme inhibitor. J Clin Gastroenterol 2000; 31:254-257.
12. Mullins RJ, Shanahan TM, Dobson RT. Visceral angioedema related to treatment with an ACE inhibitor. Med J Aust 1996; 165:319-321.
13. Schmidt TD, McGrath KM. Angiotensin-converting enzyme inhibitor angioedema of the intestine: a case report and review of the literature. Am J Med Sci 2002; 324:106-108.
14. Smoger SH, Sayed MA. Simultaneous mucosal and small bowel angioedema due to captopril. South Med J 1998; 91:1060-1063.
15. Tojo A, Onozato ML, Fujita T. Repeated subileus due to angioedema during renin-angiotensin system blockade. Am J Med Sci 2006; 332:36-38.
16. De Backer AI, De Schepper AM, Vandevenne JE, Schoeters P, Michielsen P, Stevens WJ. CT of angioedema of the small bowel. AJR Am J Roentgenol 2001; 176:649-652.
17. M armery H, Mirvis SE. Angiotensin-converting enzyme inhibitor-induced visceral angioedema. Clin Radiol 2006; 61:979-982.
18. O rr KK, Myers JR. Intermittent visceral edema induced by long-term enalapril administration. Ann Pharmacother 2004; 38:825-827.
19. Spahn TW, Grosse-Thie W, Mueller MK. Endoscopic visualization of angiotensin-converting enzyme inhibitor-induced small bowel angioedema as a cause of relapsing abdominal pain using double-balloon enteroscopy. Dig Dis Sci 2008; 53:1257-1260.
20. Byrne TJ, Douglas DD, Landis ME, Heppell JP. Isolated visceral angioedema: an underdiagnosed complication of ACE inhibitors? Mayo Clin Proc 2000; 75:1201-1204.
21. Rosenberg EI, Mishra G, Abdelmalek MF. Angiotensin-converting enzyme inhibitor-induced isolated visceral angioedema in a liver transplant recipient. Transplantation 2003; 75:730-732.
22. Salloum H, Locher C, Chenard A, et al. [Small bowel angioedema due to perindopril]. Gastroenterol Clin Biol 2005; 29:1180-1181.
23. Arakawa M, Murata Y, Rikimaru Y, Sasaki Y. Drug-induced isolated visceral angioneurotic edema. Intern Med 2005; 44:975-978.
24. Abdelmalek MF, Douglas DD. Lisinopril-induced isolated visceral angioedema: review of ACE-inhibitor-induced small bowel angioedema. Dig Dis Sci 1997; 42:847-850.
25. Gregory KW, Davis RC. Images in clinical medicine. Angioedema of the intestine. N Engl J Med 1996; 334:1641.
26. Farraye FA, Peppercorn MA, Steer ML, Joffe N, Rees M. Acute small-bowel mucosal edema following enalapril use. JAMA 1988; 259:3131.
27. J acobs RL, Hoberman LJ, Goldstein HM. Angioedema of the small bowel caused by an angiotensin-converting enzyme inhibitor. Am J Gastroenterol 1994; 89:127-128.
28. Herman L, Jocums SB, Coleman MD. A 29-year-old woman with crampy abdominal pain. Tenn Med 1999; 92:272-273.
29. Guy C, Cathébras P, Rousset H. Suspected angioedema of abdominal viscera. Ann Intern Med 1994; 121:900.
30. Dupasquier E. [A rare clinical form of angioneurotic edema caused by enalapril: acute abdomen]. Arch Mal Coeur Vaiss 1994; 87:1371-1374.
31. J ardine DL, Anderson JC, McClintock AD. Delayed diagnosis of recurrent visceral angio-oedema secondary to ACE inhibitor therapy. Aust N Z J Med 1999; 29:377-378.
32. M atsumura M, Haruki K, Kajinami K, Takada T. Angioedema likely related to angiotensin converting enzyme inhibitors. Intern Med 1993; 32:424-426.
33. Khan MU, Baig MA, Javed RA, et al. Benazepril induced isolated visceral angioedema: a rare and under diagnosed adverse effect of angiotensin converting enzyme inhibitors. Int J Cardiol 2007; 118:e68-e69.
34. Adhikari SP, Schneider JI. An unusual cause of abdominal pain and hypotension: angioedema of the bowel. J Emerg Med 2009; 36:23-25.
35. Gibbs CR, Lip GY, Beevers DG. Angioedema due to ACE inhibitors: increased risk in patients of African origin. Br J Clin Pharmacol 1999; 48:861-865.
36. Johnsen SP, Jacobsen J, Monster TB, Friis S, McLaughlin JK, Sørensen HT. Risk of first-time hospitalization for angioedema among users of ACE inhibitors and angiotensin receptor antagonists. Am J Med 2005; 118:1428-1329.
37. Bi CK, Soltani K, Sloan JB, Weber RR, Elliott WJ, Murphy MB. Tissue-specific autoantibodies induced by captopril. Clin Res 1987; 35:922A.
38. Bork K, Dewald G. Hereditary angioedema type III, angioedema associated with angiotensin II receptor antagonists, and female sex. Am J Med 2004; 116:644-645.
39. W itten DM, Hirsch FD, Hartman GW. Acute reactions to urographic contrast medium: incidence, clinical characteristics and relationship to history of hypersensitivity states. Am J Roentgenol Radium Ther Nucl Med 1973; 119:832-840.
40. Eck SL, Morse JH, Janssen DA, Emerson SG, Markovitz DM. Angioedema presenting as chronic gastrointestinal symptoms. Am J Gastroenterol 1993; 88:436-439.
41. Coleman JW, Yeung JH, Roberts DH, Breckenridge AM, Park BK. Drug-specific antibodies in patients receiving captopril. Br J Clin Pharmacol 1986; 22:161-165.
42. Kallenberg CG. Autoantibodies during captopril treatment. Arthritis Rheum 1985; 28:597-598.
43. Inman WH, Rawson NS, Wilton LV, Pearce GL, Speirs CJ. Postmarketing surveillance of enalapril. I: Results of prescriptionevent monitoring. BMJ 1988; 297:826-829.
44. Lefebvre J, Murphey LJ, Hartert TV, Jiao Shan R, Simmons WH, Brown NJ. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension 2002; 39:460-464.
45. M olinaro G, Cugno M, Perez M, et al. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin. J Pharmacol Exp Ther 2002; 303:232-237.
46. Adam A, Cugno M, Molinaro G, Perez M, Lepage Y, Agostoni A. Aminopeptidase P in individuals with a history of angiooedema on ACE inhibitors. Lancet 2002; 359:2088-2089.
47. Binkley KE, Davis A 3rd. Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 2000; 106:546- 550.
48. Yeung JH, Coleman JW, Park BK. Drug-protein conjugates-IX. Immunogenicity of captopril-protein conjugates. Biochem Pharmacol 1985; 34:4005-4012.
49. Abbosh J, Anderson JA, Levine AB, Kupin WL. Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients. Ann Allergy Asthma Immunol 1999; 82:473-476.
50. Pichler WJ, Lehner R, Späth PJ. Recurrent angioedema associated with hypogonadism or anti-androgen therapy. Ann Allergy 1989; 63:301-305.
51. Bass G, Honan D. Octaplas is not equivalent to fresh frozen plasma in the treatment of acute angioedema. Eur J Anaesthesiol 2007; 24:1062-1063.
52. Bas M, Hoffmann TK, Bier H, Kojda G. Increased C-reactive protein in ACE-inhibitor-induced angioedema. Br J Clin Pharmacol 2005; 59:233-238.
53. Herman AG. Differences in structure of angiotensin-converting enzyme inhibitors might predict differences in action. Am J Cardiol 1992; 70:102C-108C.
54. Cunnion KM, Lee JC, Frank MM. Capsule production and growth phase influence binding of complement to Staphylococcus aureus. Infect Immunol 2001; 69:6796- 6803.
55. Cunnion KM, Wagner E, Frank MM. Complement and kinins. In: Parlow TG, Stites DP, Imboden JB, editors. Medical Immunology. 10th ed. New York, NY: Lange Medical Books; 2001:186-188.
56. Pellacani A, Brunner HR, Nussberger J. Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects. Clin Sci (Lond) 1994; 87:567-574.
57. Bristol-Myers Squibb Pharmaceutical Research Institute. FDA Advisory Committee Briefing Book for OMAPATRILAT Tablets NDA 21-188. www.fda.gov/ohrms/dockets/ac/02/briefing/3877B2_01_BristolMeyersSquibb.pdf. Accessed 2/4/2011.
58. Kostis JB, Kim HJ, Rusnak J, et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005; 165:1637-1642.
59. Mahoney EJ, Devaiah AK. Angioedema and angiotensinconverting enzyme inhibitors: are demographics a risk? Otolaryngol Head Neck Surg 2008; 139:105-108.
60. Warner KK, Visconti JA, Tschampel MM. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacother 2000; 34:526-528.
61. Kyrmizakis DE, Papadakis CE, Liolios AD, et al. Angiotensinconverting enzyme inhibitors and angiotensin II receptor antagonists. Arch Otolaryngol Head Neck Surg 2004; 130:1416-1419.
62. M acLean JA, Hannaway PJ. Angioedema and AT1 receptor blockers: proceed with caution. Arch Intern Med 2003; 163:1488-1489
63. Abdi R, Dong VM, Lee CJ, Ntoso KA. Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema. Pharmacotherapy 2002; 22:1173-1175.
64. Lin RY, Shah SN. Increasing hospitalizations due to angioedema in the United States. Ann Allergy Asthma Immunol 2008; 101:185-192.
65. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA 1988; 260:967-970.
66. M orimoto T, Gandhi TK, Fiskio JM, et al. An evaluation of risk factors for adverse drug events associated with angiotensin-converting enzyme inhibitors. J Eval Clin Pract 2004; 10:499-509.
67. Cohen N, Sharon A, Golik A, Zaidenstein R, Modai D. Hereditary angioneurotic edema with severe hypovolemic shock. J Clin Gastroenterol 1993; 16:237-239.
68. Ciaccia D, Brazer SR, Baker ME. Acquired C1 esterase inhibitor deficiency causing intestinal angioedema: CT appearance. AJR Am J Roentgenol 1993; 161:1215-1216.
69. M alcolm A, Prather CM. Intestinal angioedema mimicking Crohn's disease. Med J Aust 1999; 171:418-420.
70. Schmidt TD, McGrath KM. Angiotensin-converting enzyme inhibitor angioedema of the intestine: a case report and review of the literature. Am J Med Sci 2002; 324:106-108.
71. Karim MY, Masood A. Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema. J Allergy Clin Immunol 2002; 109:370-371.
72. Warrier MR, Copilevitz CA, Dykewicz MS, Slavin RG. Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema. Ann Allergy Asthma Immunol 2004; 92:573-575.
73. Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: role of bradykinin. Allergy 2007; 62:842-856.
74. Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffré D, Nussberger J. Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology 1999; 44:21-25.